Frost & Sullivan Recognises Speedel's Outstanding Entrepreneurship in Pharmaceutical and Biotechnology Market.

PR Newswire Europe, February, 2007

LONDON, February 19 /PRNewswire/ -- The 2006 Frost & Sullivan Entrepreneurial Company Award is presented to Switzerland-based biotechnology company Speedel for demonstrating superior entrepreneurial ability in the pharmaceutical and biotechnology industry. Speedel has successfully focused on unmet medical needs in the cardiovascular area with its renin inhibitors in particular, offering significant market potential.

"Speedel's main aim is to create a family of renin inhibitors as the gold standard in the treatment of cardiovascular and related diseases in the next decade," notes Frost & Sullivan Industry Analyst Paljit Mudhar. "To this end, the company is building on its established world leadership in this new mode of action, and improving the properties...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here